Related Experiment Video
Updated: Jun 10, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
ANCA-positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin-induced
Deepali Sen1, Elliot D Rosenstein, Neil Kramer
1Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ 07039, USA.
Abstract:
Although autoimmune syndromes such as systemic lupus erythematosus and dermatomyositis have been previously reported in association with statin use, vasculitis has not been well described. We present a patient with an antineutrophil cytoplasmic antibody-positive, predominantly cutaneous vasculitis, the temporal course of which was associated with simvastatin/ezetimibe use. The patient's serologic findings were consistent with drug-induced disease, with high titer antimyeloperoxidase, in addition to antinuclear and anti-Ro (SSA) antibodies. The patient demonstrated complete resolution of symptoms simply by withdrawing the drug.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Myocarditis III: Medical Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction